This application note from Qiagen presents an example workflow for detecting rare cancer mutations from large next-generation sequencing panels using QCI Interpret One clinical decision support software and interpretation service.
The software delivers variant- and disease-specific evidence for genes in somatic panels. The classifications are based on the peer-reviewed publications, oncologist-reviewed interpretation, and expert second opinion. The software also offers a variant classification system coupled with the evidence of pathogenicity, clinical actionability, and various filtering options.
Offered Free by: Qiagen
See All Resources from: Qiagen